Home › Kanser sa Suso › Texas › League City
Pag-aaral pangklinika para sa Kanser sa Suso sa League City, TX
Isang pag-aaral para sa Kanser sa Suso ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa League City. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
Nagre-recruitPhase 1
- NEXT Houston, Galveston · 23 mi ang layo
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Nagre-recruitPhase 3
- Tranquility Research, Webster · 3 mi ang layo
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Nagre-recruitPhase 3
- Tranquil Clinical Research, Webster · 3 mi ang layo
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Nagre-recruitPhase 3
- UT MD Anderson - League City, League City
- Houston Methodist Saint John Hospital, Nassau Bay · 3 mi ang layo
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
Nagre-recruitPhase 2
- Tranquil Clinical Research, Webster · 3 mi ang layo
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
- The University of Texas, MD Anderson Cancer Center - League City, League City
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Nagre-recruitPhase 3
- MD Anderson League City, League City
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Nagre-recruitPhase 3
- MD Anderson League City, League City
- Houston Methodist Saint John Hospital, Nassau Bay · 3 mi ang layo
- University of Texas Medical Branch, Galveston · 23 mi ang layo
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
Nagre-recruitObservasyonal na pag-aaral
- MD Anderson League City, Nassau Bay · 3 mi ang layo
Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery
Nagre-recruit
- University of Texas Medical Branch at Galveston, TX, Galveston · 23 mi ang layo
THRIVE Well Cancer FDTN/Exercise_Creatine Supplementation
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- The University of Texas Medical Branch, Galveston, Galveston · 23 mi ang layo
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Nagre-recruitObservasyonal na pag-aaral
- University of Texas Medical Branch, League City
- Texas Oncology - Webster, Webster · 3 mi ang layo
Pag-aaral para sa Kanser sa Suso sa ibang lungsod
- New York City, NY136 pag-aaral
- Houston, TX126 pag-aaral
- Boston, MA112 pag-aaral
- Nashville, TN81 pag-aaral
- Los Angeles, CA73 pag-aaral
- Edison, NJ68 pag-aaral
- St. Louis, MO64 pag-aaral
- Queens, NY64 pag-aaral
- Durham, NC64 pag-aaral
- Chicago, IL59 pag-aaral
- Philadelphia, PA56 pag-aaral
- Dallas, TX55 pag-aaral
Iba pang pag-aaral sa League City
- Non-Small Cell Lung Cancer15 pag-aaral
- Metastatic Cancer7 pag-aaral
- Ulcerative Colitis6 pag-aaral
- Kanser sa Baga6 pag-aaral
- Colorectal Cancer6 pag-aaral
- Kanser (lahat ng uri)5 pag-aaral
- Kanser sa Ovary5 pag-aaral
- Stroke5 pag-aaral
- Kanser sa Pantog4 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg4 pag-aaral
- Kanser sa Prostate4 pag-aaral
- Post-COVID Conditions (Long COVID)3 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.